COMPANY
Clinical Phase 1
Keywords: vaccine infectious disease infectious diseases oncology Nipah Virus Infection Ebola Virus Disease
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1: Safety and Immunogenicity of a Nipah Virus Vaccine source ↗
- Trial start Phase 1: Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT04199169 | Safety and Immunogenicity of a Nipah Virus Vaccine | Phase 1 | Completed | Feb 18, 2020 | May 6, 2022 (actual) |
| NCT02718469 | Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults | Phase 1 | Completed | Dec 22, 2015 | Sep 15, 2016 (actual) |
